Anaptysbio (ANAB) Current Assets (2016 - 2026)
Anaptysbio (ANAB) recorded Current Assets of $316.11 million in Q1 2026, down 12.9% from $363.11 million a year earlier and down 9.7% from the prior quarter.
Anaptysbio (ANAB) Current Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Anaptysbio reported Current Assets of $350.25 million, down 18.9% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of -2.5% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $431.88 million in FY2024 (+6.2%), $406.84 million in FY2023 (-9.0%), $447.21 million in FY2022 (-19.3%) and $553.88 million in FY2021 (+39.7%).
- Quarterly Current Assets has ranged from $291.91 million in Q2 2025 to $553.88 million in Q4 2021 over the past five years.
- On a year-over-year basis, Current Assets has declined for five consecutive quarters, with an average decline of 10.8% over the last eight quarters.
- Peak year-over-year performance for Current Assets in the last five years was growth of 39.7% in Q4 2021, against a decline of 26.3% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $350.25 million (Q4 2025), $330.65 million (Q3 2025) and $291.91 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Anaptysbio | 1.37 Bn | 260.54 Mn | - | 316.11 Mn |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 316.11 Mn |
| Dec 31, 2025 | 350.25 Mn |
| Sep 30, 2025 | 330.65 Mn |
| Jun 30, 2025 | 291.91 Mn |
| Mar 31, 2025 | 363.11 Mn |
| Dec 31, 2024 | 431.88 Mn |
| Sep 30, 2024 | 448.68 Mn |
| Jun 30, 2024 | 367.35 Mn |
| Mar 31, 2024 | 372.42 Mn |
| Dec 31, 2023 | 406.84 Mn |
| Sep 30, 2023 | 428.00 Mn |
| Jun 30, 2023 | 438.54 Mn |
| Mar 31, 2023 | 437.15 Mn |
| Dec 31, 2022 | 447.21 Mn |
| Sep 30, 2022 | 450.44 Mn |
| Jun 30, 2022 | 452.81 Mn |
| Mar 31, 2022 | 512.41 Mn |
| Dec 31, 2021 | 553.88 Mn |
| Sep 30, 2021 | 386.64 Mn |
| Jun 30, 2021 | 398.06 Mn |
Anaptysbio Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ANAB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();